Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Market Insights | Latin America (Supplemental) | 2021

Although the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020, the Latin America market for IC devices will expand moderately through 2029; driven by an expanding CAD patient pool and increasing adoption of premium-priced devices—such as next generation DES and intravascular imaging catheters and pressure guidewires—supporting revenues. However, continuing budgetary constraints among Latin American facilities will inhibit uptake of high-cost products and limit overall market growth. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional cardiology devices in Argentina, Brazil, Colombia, and Mexico across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectables market will expand through 2035, driven by ongoing product innovation and differentiation strategies among key competitors, as well as the increasing…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market will experience steady moderate growth through 2035, supported by the gradual expansion of MIS volumes and selective adoption of highervalue…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…